Skip to main content
Premium Trial:

Request an Annual Quote

Regeneron Genetics Center Taps DNAnexus' Platform to Support Genomic Research Activities

Premium

NEW YORK (GenomeWeb) – DNAnexus said this week that its cloud-based data management and analysis platform is being used in partnerships between Regeneron Genetics Center (RGC) and healthcare providers that are focused on integrating next-generation sequence data with de-identified clinical records.

DNAnexus' platform will be used to share and manage data in various RGC research partnerships including one collaboration with the Geisinger Health System that will sequence 100,000 de-identified DNA samples. The RGC will use DNAnexus' infrastructure to integrate the sequence data with corresponding de-identified clinical information.

"Our collaboration with DNAnexus has been crucial in enabling the RGC to build the first large-scale genome sequencing center using entirely cloud-based genome informatics and data management," Jeffrey Reid, RGC's head of genome informatics, said in a statement. The system supports "seamless and secure interactions with our collaborators, like Geisinger, and has been essential in bringing the RGC online and rapidly scaling-up to more than 1,000 exomes sequenced per week."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.